Weiskopf, Kipp
Massachusetts Institute of Technology,
United States
2025 Rank: 82,363
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,531 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82,363 | 92,395 |
| Total Cites | 600 | 615 |
| H-index | 12 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 30 | 31 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 153 | 160 |
| Number of Single+First+Last Authored Papers | 13 | 13 |
| Total Cites to Single+First+Last Authored Papers | 162 | 169 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 440 | 449 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.37 |
| Self-Citation Percentage |
2.44%
|
|
Weiskopf, Kipp
Dana-Farber Cancer Institute,
United States
2024 Rank: 70,401
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,422 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70,401 | 76,392 |
| Total Cites | 677 | 690 |
| H-index | 12 | 13 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 40 | 41 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 161 | 164 |
| Number of Single+First+Last Authored Papers | 12 | 12 |
| Total Cites to Single+First+Last Authored Papers | 161 | 164 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 487 | 498 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.39 |
| Self-Citation Percentage |
1.88%
|
|
Weiskopf, Kipp
Dana-Farber Cancer Institute,
United States
2023 Rank: 66,350
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,491 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66,350 | 75,714 |
| Total Cites | 705 | 734 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 36 | 36 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 158 | 163 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 158 | 163 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 501 | 515 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.43 |
| Self-Citation Percentage |
3.95%
|
|
Weiskopf, Kipp
Stanford University School of Medicine,
United States
2022 Rank: 48,094
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,216 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48,094 | 55,765 |
| Total Cites | 748 | 770 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 48 | 48 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 195 | 200 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 195 | 200 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 484 | 498 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.55 |
| Self-Citation Percentage |
2.86%
|
|
Weiskopf, Kipp
Stanford University School of Medicine,
United States
2021 Rank: 49,431
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,148 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49,431 | 56,423 |
| Total Cites | 1,037 | 1,084 |
| H-index | 15 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 80 | 81 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 275 | 285 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 275 | 285 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 640 | 666 |
| Ratio of Total Citations to Distinct Citing Papers | 1.62 | 1.63 |
| Self-Citation Percentage |
4.34%
|
|
Weiskopf, Kipp
Stanford University School of Medicine,
United States
2020 Rank: 51,328
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,107 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51,328 | 55,582 |
| Total Cites | 700 | 762 |
| H-index | 14 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 65 | 66 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 199 | 208 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 199 | 208 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 456 | 485 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.57 |
| Self-Citation Percentage |
8.14%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.